Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

COVID-19: Daily Top 10 Papers


  Free Subscription


1 Acta Haematol
1 Am J Hematol
3 Ann Hematol
1 Biochem Biophys Res Commun
10 Blood
1 Bone Marrow Transplant
1 Br J Haematol
1 Exp Hematol
1 Hematol Oncol Clin North Am
4 Int J Hematol
2 J Clin Oncol
4 J Pediatr Hematol Oncol
3 Leuk Lymphoma
2 Leuk Res
7 Leukemia
1 PLoS One

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Acta Haematol

  1. DANYLESKO I, Canaani J, Shimoni A, Fein J, et al
    Complete Remission with Incomplete Blood Count Recovery Is a Strong Predictor of Nonrelapse Mortality in Acute Myeloid Leukemia Patients Undergoing Allogeneic Stem Cell Transplantation.
    Acta Haematol. 2021 Jun 8:1-7. doi: 10.1159/000515902.
    PubMed         Abstract available

    Am J Hematol

  2. AL-SAWAF O, Gentile B, Devine J, Zhang C, et al
    Health-related quality of life with fixed-duration venetoclax-obinutuzumab for previously untreated chronic lymphocytic leukemia: Results from the randomized, phase 3 CLL14 trial.
    Am J Hematol. 2021 May 29. doi: 10.1002/ajh.26260.
    PubMed         Abstract available

    Ann Hematol

  3. KRECAK I, Cengic M, Skoric I, Nakic M, et al
    Concomitant autoimmune hemolytic anemia and pure red cell aplasia in a patient with chronic lymphocytic leukemia successfully treated with ibrutinib.
    Ann Hematol. 2021 Jun 10. pii: 10.1007/s00277-021-04570.

  4. DOU X, Zheng F, Zhang L, Jin J, et al
    Adolescents experienced more treatment failure than children with chronic myeloid leukemia receiving imatinib as frontline therapy: a retrospective multicenter study.
    Ann Hematol. 2021 Jun 5. pii: 10.1007/s00277-021-04544.
    PubMed         Abstract available

  5. AL-SARAYFI D, Meeuwes FO, Munnink TO, Plattel W, et al
    Successful treatment of hairy cell leukemia variant with obinutuzumab.
    Ann Hematol. 2021 Jun 4. pii: 10.1007/s00277-021-04559.

    Biochem Biophys Res Commun

  6. PENG H, Zou Y
    The leukocyte immunoglobulin-like receptor gp49B1, coexpressed with c-Kit, modulates hematopoiesis and B cell leukemia development.
    Biochem Biophys Res Commun. 2021;565:72-78.
    PubMed         Abstract available


  7. STEVENSON FK, Forconi F, Kipps TJ
    Exploring the Pathways to Chronic Lymphocytic Leukemia.
    Blood. 2021 Jun 1. pii: 476048. doi: 10.1182/blood.2020010029.
    PubMed         Abstract available

  8. AWADA H, Durmaz A, Gurnari C, Kishtagari A, et al
    Machine Learning Integrates Genomic Signatures for Subclassification Beyond Primary and Secondary Acute Myeloid Leukemia.
    Blood. 2021 Jun 1. pii: 476049. doi: 10.1182/blood.2020010603.
    PubMed         Abstract available

  9. DUAULT C, Kumar A, Taghi Khani A, Lee SJ, et al
    Activated Natural Killer Cells Predict Poor Clinical Prognosis in High-risk B- and T- cell Acute Lymphoblastic Leukemia.
    Blood. 2021 Jun 2. pii: 476053. doi: 10.1182/blood.2020009871.
    PubMed         Abstract available

  10. BOLDRIN E, Gaffo E, Niedermayer A, Boer JM, et al
    MicroRNA-497/195 is tumor-suppressive and cooperates with CDKN2A/B in pediatric acute lymphoblastic leukemia.
    Blood. 2021 Jun 7. pii: 476100. doi: 10.1182/blood.2020007591.
    PubMed         Abstract available

  11. CHANG Y, Min J, Jarusiewicz J, Actis M, et al
    Degradation of Janus kinases in CRLF2-rearranged acute lymphoblastic leukemia.
    Blood. 2021 Jun 10. pii: 476126. doi: 10.1182/blood.2020006846.
    PubMed         Abstract available

  12. MALOUF C, Antunes ETB, O'Dwyer M, Jakobczyk H, et al
    MiR-130b and miR-128a are essential lineage-specific co-drivers of t(4;11) MLL-AF4 acute leukemia.
    Blood. 2021 Jun 10. pii: 476129. doi: 10.1182/blood.2020006610.
    PubMed         Abstract available

  13. LV K, Ren JG, Han X, Gui J, et al
    Depalmitoylation Rewires FLT3-ITD Signaling and Exacerbates Leukemia Progression.
    Blood. 2021 Jun 10. pii: 476131. doi: 10.1182/blood.2021011582.
    PubMed         Abstract available

  14. TANAKA T, Morita K, Wang F, Loghavi S, et al
    Clonal Dynamics and clinical implications of Post-Remission Clonal Hematopoiesis in Acute Myeloid Leukemia (AML).
    Blood. 2021 Jun 3. pii: 476064. doi: 10.1182/blood.2020010483.
    PubMed         Abstract available

  15. JONES RJ, DeBaun MR
    Leukemia after gene therapy for sickle cell disease: insertional mutagenesis, busulfan, both or neither.
    Blood. 2021 Jun 3. pii: 476065. doi: 10.1182/blood.2021011488.
    PubMed         Abstract available

  16. RUBNITZ JE, Kaspers GJL
    How I treat pediatric acute myeloid leukemia.
    Blood. 2021 Jun 11. pii: 476140. doi: 10.1182/blood.2021011694.
    PubMed         Abstract available

    Bone Marrow Transplant

  17. WAIDHAUSER J, Labopin M, Esteve J, Kroger N, et al
    Allogeneic stem cell transplantation for AML patients with RUNX1 mutation in first complete remission: a study on behalf of the acute leukemia working party of the EBMT.
    Bone Marrow Transplant. 2021 May 31. pii: 10.1038/s41409-021-01322.
    PubMed         Abstract available

    Br J Haematol

  18. OSTERGAARD J, Jonart LM, Ebadi M, Koppenhafer SL, et al
    Preclinical efficacy of prexasertib in acute lymphoblastic leukemia.
    Br J Haematol. 2021 Jun 7. doi: 10.1111/bjh.17610.

    Exp Hematol

  19. KAEHLER M, Dworschak M, Rodin JP, Ruemenapp J, et al
    ZFP36L1 plays an ambiguous role in the regulation of cell expansion and negatively regulates CDKN1A in chronic myeloid leukemia cells.
    Exp Hematol. 2021 Jun 3. pii: S0301-472X(21)00199.
    PubMed         Abstract available

    Hematol Oncol Clin North Am

  20. AL-SAWAF O, Seymour JF, Kater AP, Fischer K, et al
    Should Undetectable Minimal Residual Disease Be the Goal of Chronic Lymphocytic Leukemia Therapy?
    Hematol Oncol Clin North Am. 2021 May 15. pii: S0889-8588(21)00039.
    PubMed         Abstract available

    Int J Hematol

  21. SHAN M, Lu Y, Yang M, Wang P, et al
    Characteristics and transplant outcome of myeloid sarcoma: a single-institute study.
    Int J Hematol. 2021;113:682-692.
    PubMed         Abstract available

  22. MORI T, Kikuchi T, Yamazaki R, Koda Y, et al
    Phase 1 study of plerixafor in combination with total body irradiation-based myeloablative conditioning for allogeneic hematopoietic stem cell transplantation.
    Int J Hematol. 2021;113:877-883.
    PubMed         Abstract available

  23. KIMURA S
    Evolution of CML treatment.
    Int J Hematol. 2021;113:622-623.

  24. MORITA K, Sasaki K
    Current status and novel strategy of CML.
    Int J Hematol. 2021;113:624-631.
    PubMed         Abstract available

    J Clin Oncol

  25. WEI AH, Roboz GJ, Kantarjian HM
    Harnessing the Therapeutic Value of Venetoclax: A Breakthrough Therapy in Acute Myeloid Leukemia.
    J Clin Oncol. 2021 Jun 4:JCO2100080. doi: 10.1200/JCO.21.00080.

  26. ZHENG H, Jiang H, Hu S, Liao N, et al
    Arsenic Combined With All-Trans Retinoic Acid for Pediatric Acute Promyelocytic Leukemia: Report From the CCLG-APL2016 Protocol Study.
    J Clin Oncol. 2021 Jun 2:JCO2003096. doi: 10.1200/JCO.20.03096.
    PubMed         Abstract available

    J Pediatr Hematol Oncol

  27. KALRA K, Arora S, Verma S, Pushpam D, et al
    Autologous Hematopoietic Stem Cell Transplant: A Potential Option for Relapsed Pediatric Acute Myeloid Leukemia With Lack of Matched Sibling Donor and Resource Challenge.
    J Pediatr Hematol Oncol. 2021 May 31. pii: 00043426-900000000-96867.
    PubMed         Abstract available

  28. ZHENG Y, Wen J, Li J
    Pediatric Chronic Myeloid Leukemia Presenting With Extreme Thrombocytosis and Acute Upper Gastrointestinal Hemorrhage: A Case Report.
    J Pediatr Hematol Oncol. 2021 May 31. pii: 00043426-900000000-96864.

  29. ROLDAN GALIACHO V, Moreno Gamiz M, Echebarrria-Barona A
    Aggregates of Pseudogaucher Cells in a Pediatric Patient With Chronic Myeloid Leukemia.
    J Pediatr Hematol Oncol. 2021 May 31. pii: 00043426-900000000-96862.

  30. AYLAN GELEN S, Sarper N, Zengin E, Azizoglu M, et al
    Management of Hyperleukocytosis in Childhood Acute Leukemia Without Leukapheresis and Rasburicase Prophylaxis.
    J Pediatr Hematol Oncol. 2021 May 31. pii: 00043426-900000000-96860.
    PubMed         Abstract available

    Leuk Lymphoma

  31. BOULLAND ML, Vic S, Thonier F, Ganard M, et al
    Reliable IGHV status assessment by next generation sequencing in routine practice for chronic lymphocytic leukemia.
    Leuk Lymphoma. 2021 Jun 1:1-4. doi: 10.1080/10428194.2021.1933476.

  32. STUBBINS RJ, Maksakov IA, Sanford DS, Rouhi A, et al
    Mitochondrial metabolism: powering new directions in acute myeloid leukemia.
    Leuk Lymphoma. 2021 Jun 1:1-11. doi: 10.1080/10428194.2021.1910685.
    PubMed         Abstract available

  33. KHAZAL S, Kebriaei P
    Hematopoietic cell transplantation for acute lymphoblastic leukemia: review of current indications and outcomes.
    Leuk Lymphoma. 2021 Jun 3:1-14. doi: 10.1080/10428194.2021.1933475.
    PubMed         Abstract available

    Leuk Res

  34. YASUDA S, Najima Y, Konishi T, Yamada Y, et al
    Outcome of allogeneic hematopoietic stem cell transplantation for T-cell lymphoblastic leukemia/lymphoma: A single-center study.
    Leuk Res. 2021;108:106627.
    PubMed         Abstract available

  35. SONG J, Shang B, Pei Y, Shi M, et al
    A higher percentage of leukemic blasts with vacuoles predicts unfavorable outcomes in patients with acute myeloid leukemia.
    Leuk Res. 2021;109:106638.
    PubMed         Abstract available


    Prevention of childhood leukaemia by lifestyle changes.
    Leukemia. 2021;35:1265-1266.

  37. MAYANSKIY N, Luchkina P, Fedorova N, Lebedin Y, et al
    Seroconversion and dynamics of the anti-SARS-CoV-2 antibody response related to a hospital COVID-19 outbreak among pediatric oncology patients.
    Leukemia. 2021;35:1820-1822.

  38. KIM D, Park G, Huuhtanen J, Ghimire B, et al
    STAT3 activation in large granular lymphocyte leukemia is associated with cytokine signaling and DNA hypermethylation.
    Leukemia. 2021 Jun 1. pii: 10.1038/s41375-021-01296.
    PubMed         Abstract available

  39. WIEDUWILT MJ, Stock W, Advani A, Luger S, et al
    Correction: Superior survival with pediatric-style chemotherapy compared to myeloablative allogeneic hematopoietic cell transplantation in older adolescents and young adults with Ph-negative acute lymphoblastic leukemia in first complete remission: an
    Leukemia. 2021 Jun 4. pii: 10.1038/s41375-021-01303.

  40. DHAKAL B, Patel S, Girnius S, Bachegowda L, et al
    Correction to: Hematopoietic cell transplantation utilization and outcomes for primary plasma cell leukemia in the current era.
    Leukemia. 2021 Jun 5. pii: 10.1038/s41375-021-01304.

  41. KANTARJIAN HM, Hughes TP, Larson RA, Kim DW, et al
    Correction to: Long-term outcomes with frontline nilotinib versus imatinib in newly diagnosed chronic myeloid leukemia in chronic phase: ENESTnd 10-year analysis.
    Leukemia. 2021 Jun 9. pii: 10.1038/s41375-021-01306.

  42. LI Z, Jiang N, Lim EH, Chin WHN, et al
    Role of transcriptome sequencing in clinical diagnosis of B-cell acute lymphoblastic leukemia.
    Leukemia. 2021 Jun 10. pii: 10.1038/s41375-021-01185.

    PLoS One

  43. YU W, Wang W, Yu X
    Investigation of lncRNA-mRNA co-expression network in ETV6-RUNX1-positive pediatric B-cell acute lymphoblastic leukemia.
    PLoS One. 2021;16:e0253012.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.